5,180 Shares in e.l.f. Beauty $ELF Acquired by Freestone Capital Holdings LLC

Key Points

• Freestone Capital Holdings LLC acquired 5,180 shares of e.l.f. Beauty, valued at approximately $325,000, marking a significant institutional investment in the company.
• e.l.f. Beauty's stock has shown strong performance, with a one-year price range of $49.40 to $172.49 and a current market cap of $7.33 billion.
• Institutional investors hold 92.44% of e.l.f. Beauty's stock, indicating robust interest and confidence from major investment firms.

Freestone Capital Holdings LLC acquired a new position in e.l.f. Beauty (NYSE:ELF - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 5,180 shares of the company's stock, valued at approximately $325,000.

A number of other large investors also recently bought and sold shares of ELF. Rockefeller Capital Management L.P. bought a new position in e.l.f. Beauty in the fourth quarter worth approximately $1,465,000. CreativeOne Wealth LLC purchased a new position in e.l.f. Beauty in the fourth quarter worth $264,000. Dimensional Fund Advisors LP grew its holdings in e.l.f. Beauty by 9.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 456,433 shares of the company's stock worth $57,310,000 after purchasing an additional 39,549 shares during the last quarter. Capital World Investors grew its holdings in e.l.f. Beauty by 294.9% in the fourth quarter. Capital World Investors now owns 418,852 shares of the company's stock worth $52,587,000 after purchasing an additional 312,776 shares during the last quarter. Finally, MetLife Investment Management LLC grew its holdings in e.l.f. Beauty by 8.0% in the fourth quarter. MetLife Investment Management LLC now owns 34,077 shares of the company's stock worth $4,278,000 after purchasing an additional 2,533 shares during the last quarter. Institutional investors own 92.44% of the company's stock.

e.l.f. Beauty Price Performance

NYSE:ELF opened at $123.60 on Tuesday. e.l.f. Beauty has a one year low of $49.40 and a one year high of $172.49. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.34 and a current ratio of 3.26. The firm has a market cap of $7.33 billion, a price-to-earnings ratio of 72.71, a PEG ratio of 2.87 and a beta of 1.57. The firm's fifty day moving average is $118.96 and its two-hundred day moving average is $88.47.

e.l.f. Beauty (NYSE:ELF - Get Free Report) last posted its quarterly earnings results on Wednesday, August 6th. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.84 by $0.05. e.l.f. Beauty had a net margin of 7.29% and a return on equity of 16.36%. The company had revenue of $353.74 million for the quarter, compared to analyst estimates of $348.99 million. During the same period in the prior year, the company earned $1.10 earnings per share. The firm's revenue was up 9.0% on a year-over-year basis. Research analysts expect that e.l.f. Beauty will post 2.38 EPS for the current year.

Insider Buying and Selling

In other news, SVP Joshua Allen Franks sold 1,496 shares of the stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $117.61, for a total transaction of $175,944.56. Following the sale, the senior vice president directly owned 120,471 shares of the company's stock, valued at $14,168,594.31. This represents a 1.23% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, Director Lauren Cooks Levitan sold 4,630 shares of the stock in a transaction dated Thursday, August 14th. The stock was sold at an average price of $118.94, for a total transaction of $550,692.20. Following the sale, the director directly owned 11,507 shares in the company, valued at approximately $1,368,642.58. The trade was a 28.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 131,219 shares of company stock valued at $15,098,642 in the last 90 days. 3.90% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities analysts have issued reports on ELF shares. Raymond James Financial lifted their price target on shares of e.l.f. Beauty from $95.00 to $105.00 and gave the stock a "strong-buy" rating in a report on Thursday, May 29th. Bank of America lifted their price target on shares of e.l.f. Beauty from $113.00 to $135.00 and gave the stock a "buy" rating in a report on Friday, June 20th. B. Riley reaffirmed a "buy" rating and issued a $150.00 price target (up from $110.00) on shares of e.l.f. Beauty in a report on Friday, June 13th. Morgan Stanley raised shares of e.l.f. Beauty from an "equal weight" rating to an "overweight" rating and lifted their price target for the stock from $114.00 to $134.00 in a report on Monday, August 11th. Finally, Deutsche Bank Aktiengesellschaft raised shares of e.l.f. Beauty from a "hold" rating to a "buy" rating and set a $121.00 price objective on the stock in a report on Friday, August 8th. Three research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, e.l.f. Beauty presently has an average rating of "Moderate Buy" and a consensus price target of $123.81.

e.l.f. Beauty Company Profile

e.l.f. Beauty, Inc is a holding company, which engages in the provision of inclusive, accessible, clean, vegan and cruelty free cosmetics and skin care products. The company focuses on the e-commerce, national retailers and international business channels. Its brands include elf, elf skin, WELL People and KEYS soulcare.

Want to see what other hedge funds are holding ELF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for e.l.f. Beauty (NYSE:ELF - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.